Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease

Journal of Hepatology

Volumn 64, Issue 2, 2016, Pages 308-315

  Pavlides, Michael ^a,b   Banerjee, Rajarshi ^c   Sellwood, Joanne ^b   Kelly, Catherine J ^c   Robson, Matthew D ^b   Booth, Jonathan C ^d   Collier, Jane ^a   Neubauer, Stefan ^b   Barnes, Eleanor ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Royal Berkshire Hospital ^*  (United Kingdom)

^d ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Iron corrected T1; LIF score; LiverMultiScan; T1 mapping

Indexed keywords

ADULT; ARTICLE; CHRONIC LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; VIRUS HEPATITIS; BIOPSY; CHRONIC HEPATITIS; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; FIBROSIS; INFLAMMATION; KAPLAN MEIER METHOD; LIVER; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM; VIROLOGY;

ADULT; BIOPSY; FEMALE; FIBROSIS; HEPATITIS, CHRONIC; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

EID: 84954365829     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.10.009     Document Type: Article

References (38)

1. V.W. Wong, W.C. Chu, G.L. Wong, R.S. Chan, A.M. Chim, A. Ong, and et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography Gut 61 2012 409 415
2. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, M. Contreras, and et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
3. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558 567
4. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version) J Hepatol 38 2003 533 540
5. G. D'Amico, G. Garcia-Tsao, and L. Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
6. R.D. Goldin, J.G. Goldin, A.D. Burt, P.A. Dhillon, S. Hubscher, J. Wyatt, and et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis J Hepatol 25 1996 649 654
7. S.R. Rawlins, C.M. Mullen, H.M. Simon, T. Kim, S.K. Landas, M.S. Walser, and et al. Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery Gastroenterol Rep 1 2013 51 57
8. T. Poynard, P. Ingiliz, L. Elkrief, M. Munteanu, P. Lebray, R. Morra, and et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers PLoS One 3 2008 e3857
9. W.M. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, D. Schuppan, and et al. Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713
10. J. Parkes, P. Roderick, S. Harris, C. Day, D. Mutimer, J. Collier, and et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease Gut 59 2010 1245 1251
11. A.E. Bohte, A. de Niet, L. Jansen, S. Bipat, A.J. Nederveen, J. Verheij, and et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C Eur Radiol 24 2014 638 648
12. S. Singh, S.K. Venkatesh, Z. Wang, F.H. Miller, U. Motosugi, R.N. Low, and et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data Clin Gastroenterol Hepatol 13 2015 440 451 e446
13. M.A. Robic, B. Procopet, S. Métivier, J.M. Péron, J. Selves, J.P. Vinel, and et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study J Hepatol 55 2011 1017 1024
14. C. Cassinotto, B. Lapuyade, A. Mouries, J.B. Hiriart, J. Vergniol, D. Gaye, and et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan(R) J Hepatol 61 2014 550 557
15. S.K. Asrani, J.A. Talwalkar, P.S. Kamath, V.H. Shah, G. Saracino, L. Jennings, and et al. Role of magnetic resonance elastography in compensated and decompensated liver disease J Hepatol 60 2014 934 939
16. L. Castera, J. Foucher, P.H. Bernard, F. Carvalho, D. Allaix, W. Merrouche, and et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
17. F. Nascimbeni, P. Lebray, L. Fedchuk, C.P. Oliveira, M.R. Alvares-da-Silva, A. Varault, and et al. Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases Clin Gastroenterol Hepatol 13 2015 763 771 e761-766
18. S. Ichikawa, U. Motosugi, H. Morisaka, K. Sano, T. Ichikawa, A. Tatsumi, and et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis Magn Reson Imaging 33 2015 26 30
19. R. Williams, R. Aspinall, M. Bellis, G. Camps-Walsh, M. Cramp, A. Dhawan, and et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis Lancet 384 2014 1953 1997
20. N. Torok, J.A. Dranoff, D. Schuppan, and S.L. Friedman Strategies and endpoints of antifibrotic drug trials Hepatology 62 2015 627 634
21. R. Mahajan, and K. Gupta Food and drug administration's critical path initiative and innovations in drug development paradigm: challenges, progress, and controversies J Pharm Bioallied Sci 2 2010 307 313
22. R. Banerjee, M. Pavlides, E.M. Tunnicliffe, S.K. Piechnik, N. Sarania, R. Philips, and et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease J Hepatol 60 2014 69 77
23. Tunnicliffe E, Robson M, Banerjee R. Medical Imaging. Application number PCT/GB2014/050815; 2014.
24. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, and et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
25. T. Heye, S.R. Yang, M. Bock, S. Brost, K. Weigand, T. Longerich, and et al. MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis Eur Radiol 22 2012 1224 1232
26. K.A. Kim, M.-S. Park, I.-S. Kim, B. Kiefer, W.-S. Chung, M.-J. Kim, and et al. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation J Magn Reson Imaging 36 2012 405 410
27. M. Haimerl, N. Verloh, C. Fellner, F. Zeman, A. Teufel, S. Fichtner- Feigl, and et al. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score Sci Rep 4 2014 5621
28. S.K. Piechnik, V.M. Ferreira, E. Dall'Armellina, L.E. Cochlin, A. Greiser, S. Neubauer, and et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold J Cardiovasc Magn Reson 12 2010 69
29. N. Ganne-Carrie, C. Christidis, C. Chastang, M. Ziol, F. Chapel, F. Imbert-Bismut, and et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study Gut 46 2000 277 282
30. L. Valenti, A.L. Fracanzani, E. Bugianesi, P. Dongiovanni, E. Galmozzi, E. Vanni, and et al. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
31. A.S. Lok, J.E. Everhart, R.T. Chung, H.Y. Kim, G.T. Everson, J.C. Hoefs, and et al. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial Hepatology 49 2009 1828 1837
32. R. Pais, F. Charlotte, L. Fedchuk, P. Bedossa, P. Lebray, T. Poynard, and et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver J Hepatol 59 2013 550 556
33. L. Castera, C. Hezode, F. Roudot-Thoraval, A. Bastie, E.S. Zafrani, J.M. Pawlotsky, and et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies Gut 52 2003 288 292
34. Y.W. Huang, S.S. Yang, S.C. Fu, T.C. Wang, C.K. Hsu, D.S. Chen, and et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study Hepatology 60 2014 807 814
35. F. Friedenberg, S. Pungpapong, N. Zaeri, and L.E. Braitman The impact of diabetes and obesity on liver histology in patients with hepatitis C Diabetes Obes Metab 5 2003 150 155
36. J. Wyatt, H. Baker, P. Prasad, Y.Y. Gong, and C. Millson Steatosis and fibrosis in patients with chronic hepatitis C J Clin Pathol 57 2004 402 406
37. C.D. Hines, T.A. Bley, M.J. Lindstrom, and S.B. Reeder Repeatability of magnetic resonance elastography for quantification of hepatic stiffness J Magn Reson Imaging 31 2010 725 731
38. R. Loomba, C.B. Sirlin, B. Ang, R. Bettencourt, R. Jain, J. Salotti, and et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) Hepatology 61 2015 1239 1250